NEWS Alternative Proteins Magazine October 2024 57 Innovafeed completes third expansion phase of industrial site Innovafeed, one of the leading insect producers for animal and plant nutrition, announced the completion of the third phase of expansion at its production site in Nesle, France. According to the company, this is a crucial step that marks the scaling up of its production capacities, as announced in September 2022, following its record-breaking €250M Series D funding round.This new expansion brings the total floor area to 55,000m². As a result, it increases the larval production capacity fivefold and enhances rearing conditions through automated and optimized production flow management. Innovafeed claims that with this expansion, Nesle will become the largest insect production site in the world. According to Innovafeed, this achievement not only demonstrates the viability of its breakthrough technology but also its ability to scale up to largescale, profitable, and sustainable production. “Innovafeed thus proves the robustness of its innovative industrial model,” the company adds. The construction of this latest expansion in Nesle is the result of an industrial development designed in phases to manage and mitigate the risks of its model. The first two phases, inaugurated in 2020 and 2023 respectively, addressed the technological risks inherent in creating a new innovative industrial sector based on living organisms. Read more>> Further Foods designs FDA trial for cultivated meat in pet food CULT Food Science Corp., a food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry, announced that its subsidiary, Further Foods Inc., expects to complete the design of the feeding trials necessary for regulatory approval of dog food products containing cell-cultivated chicken later this month. Cell-cultivated chicken is a new ingredient without prior approval for animal consumption and Further Foods is, in partnership with Dr. Sarah Dodd, designing a target animal safety (TAS) study to establish the inclusion of cell-cultivated chicken in future Noochies! formulations is safe and effective. Dr. Sarah Dodd commented, "I'm thrilled to be collaborating with Further Foods and Noochies! on this very exciting feeding trial. Cultivated meat is an area I am personally exceptionally excited about, for both its nutritional potential for animals and for its positive impact on the environment. I look forward to navigating the regulatory pathways and feeding trial requirements with the FDA and advancing this first of its kind trial forward." "This is a transformative moment for CULT Food Science as a company. We believe this FDA feeding trial will position us on the leading edge of cellular agriculture and cultivated meat innovation. But even more importantly, we believe that the implications of a successful trial could change the landscape of pet food as a whole. Cultivated meat has nutritional benefits, environmental benefits and ethical benefits for pet owners. But the regulatory pathways have yet to be successfully navigated and as a result, this is not currently an option in North America. We are seeking to be a first mover in changing that and look forward to advancing this trial in collaboration with Dr. Sarah Dodd and the FDA," said Mitchell Scott, CEO of CULT Food Science. Read more>>
RkJQdWJsaXNoZXIy MTUxNjkxNQ==